Showing results (1-10 of 677) with videos related to
Sort By:
Pageof 68
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|October 3, 2006
Coronary artery wall enhances with intracoronary injection of echocontrast media during in vivo intravascular ultrasoundOkan Gulel, Ilke Sipahi, E Murat Tuzcu, et al.Cleveland Clinic Journal of Medicine|December 24, 2015
Transcatheter aortic valve replacement: History and current indicationsAhmad Zeeshan, E Murat Tuzcu, Amar Krishnaswamy, et al.JACC. Cardiovascular Imaging|July 14, 2012
Role of echocardiography in percutaneous mitral valve interventionsJoão L Cavalcante, L Leonardo Rodriguez, Samir Kapadia, et al.The Annals of Thoracic Surgery|February 22, 2016
Postoperative Migration of an Edwards-SAPIEN XT Mitral Valve-in-Valve Treated With Direct Vision Implantation During Beating-Heart BypassStephanie L Mick, Eric E Roselli, Samir Kapadia, et al.Journal of the American College of Cardiology|March 7, 2006
Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I MilanoStephen J Nicholls, E Murat Tuzcu, Ilke Sipahi, et al.European Heart Journal|March 10, 2006
Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trialIlke Sipahi, E Murat Tuzcu, Paul Schoenhagen, et al.American Heart Journal|August 23, 2006
Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trialIlke Sipahi, E Murat Tuzcu, Paul Schoenhagen, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 20, 2020
End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the riskAaron N Dunn, Chetan Huded, Conrad Simpfendorfer, et al.The American Journal of Cardiology|December 20, 2005
Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study)Stephen J Nicholls, E Murat Tuzcu, Paul Schoenhagen, et al.Cardiovascular Diagnosis and Therapy|April 8, 2016
Peri-procedural imaging for transcatheter mitral valve replacementNavin Natarajan, Parag Patel, Thomas Bartel, et al.Pageof 68